摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-甲基-5-(苯基甲基)吡啶 | 74271-42-4

中文名称
3-甲基-5-(苯基甲基)吡啶
中文别名
二(三乙烯醇十二四烷基醚)磷酸酯
英文名称
3-benzyl-5-methylpyridine
英文别名
5-Benzyl-3-methylpyridine
3-甲基-5-(苯基甲基)吡啶化学式
CAS
74271-42-4
化学式
C13H13N
mdl
——
分子量
183.253
InChiKey
UCWQMPICSBZRLS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    12.9
  • 氢给体数:
    0
  • 氢受体数:
    1

SDS

SDS:234e12e85bae659788a5de89340fc77d
查看

反应信息

  • 作为产物:
    描述:
    1,3-dibenzyl-5-methyl-2-(trimethylsilyl)-1,2-dihydropyridine 在 palladium on activated charcoal air氢气 作用下, 以 2,2,2-三氟乙醇甲苯 为溶剂, 反应 28.0h, 以65 mg的产率得到3-甲基-5-(苯基甲基)吡啶
    参考文献:
    名称:
    Synthesis of Dihydropyridines and Pyridines from Imines and Alkynes via C−H Activation
    摘要:
    A convenient one-pot C-H alkenylation/electrocyclization/aromatization sequence has been developed for the synthesis of highly substituted pyridine derivatives from alkynes and alpha,beta-unsaturated N-benzyl aldimines and ketimines that proceeds through dihydropyridine intermediates. A new class of ligands for C-H activation was developed, providing broader scope for the alkenylation step than could be achieved with previously reported ligands. Substantial information was obtained about the mechanism of the reaction. This included the isolation of a C-H activated complex and its structure determination by X-ray analysis; in addition, kinetic simulations using the Copasi software were employed to determine rate constants for this transformation, implicating facile C-H oxidative addition and slow reductive elimination steps.
    DOI:
    10.1021/ja7104784
点击查看最新优质反应信息

文献信息

  • Regioselectively Functionalized Pyridines from Sustainable Resources
    作者:Stefan Michlik、Rhett Kempe
    DOI:10.1002/anie.201301919
    日期:2013.6.10
    Ir‐catalyzed dehydrogenative condensation of alcohols and 1,3‐amino alcohol was used to construct pyridine derivatives regioselectively. This method provides access to unsymmetrically substituted pyridines and tolerates a wide variety of functional groups. Three equivalents of H2 are generated per pyridine unit formed and the alcohol substrates become completely deoxygenated.
    充分利用它!醇和1,3-氨基醇的Ir催化脱氢缩合反应用于区域选择性地构建吡啶衍生物。该方法提供了不对称取代的吡啶的途径,并能耐受多种官能团。每个形成的吡啶单元产生三当量的H 2,醇底物完全脱氧。
  • Reactions of 1,4-Bis(trimethylsilyl)-1,4-dihydropyridines with Carbonyl Compounds: A New Method for Regioselective Synthesis of 3-Alkylpyridines
    作者:Otohiko Tsuge、Shuji Kanemasa、Toshio Naritomi、Junji Tanaka
    DOI:10.1246/bcsj.60.1497
    日期:1987.4
    A new method for the alkyl group introduction at the 3-position of pyridienes is described: Reductive disilylation of pyridine, its 2-methyl, 3-methyl, and 4-methyl derivatives affords the corresponding 1,4-disilyl-1,4-dihydropyridines. In the presence of a catalytic amount of tetrabutylammonium fluoride, these dihydropyridines smoothly react with a variety of aldehydes and ketones to give 3-alkylpyridines
    描述了在吡啶的 3-位引入烷基的新方法:吡啶的还原二甲硅烷基化,其 2-甲基、3-甲基和 4-甲基衍生物提供相应的 1,4-二甲硅烷基-1,4-二氢吡啶类。在催化量的四丁基氟化铵存在下,这些二氢吡啶与各种醛和酮顺利反应生成 3-烷基吡啶。
  • ASK1 inhibitor and preparation method and use thereof
    申请人:FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
    公开号:US10787435B2
    公开(公告)日:2020-09-29
    The present disclosure relates to a compound as shown in formula (II), a tautomer or a pharmaceutically acceptable salt thereof, and disclosed is the use thereof in preparing a drug for treating an ASK1-associated disease.
    本公开涉及一种如式(II)所示的化合物、其同系物或药学上可接受的盐,并公开了其在制备治疗 ASK1 相关疾病的药物中的用途。
  • TSUGE OTOHIKO; KANEMASA SHUJI; NARITOMI TOSHIO; TANAKA JUNJI, BULL. CHEM. SOC. JAP., 60,(1987) N 4, 1497-1504
    作者:TSUGE OTOHIKO、 KANEMASA SHUJI、 NARITOMI TOSHIO、 TANAKA JUNJI
    DOI:——
    日期:——
  • ASK1 INHIBITOR AND PREPARATION METHOD AND USE THEREOF
    申请人:Fujian Cosunter Pharmaceutical Co., Ltd.
    公开号:EP3572401B1
    公开(公告)日:2021-09-29
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-